Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
442.30    -8.80 (-1.95%)
Bid:
442.10
Ask:
442.30
Spread: 0.20 (0.045%)
Market Cap: £11.13b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Publication of Prospectus

14 Sep 2012 17:32

RNS Number : 3548M
Rentokil Initial PLC
14 September 2012
Β 

ο»Ώ

14 September 2012

Β 

Rentokil Initial plc

Publication of Supplementary Prospectus

Β 

The following prospectus has today been approved by the UK Listing Authority and is available for viewing:

Supplementary Prospectus dated 14 September 2012 in respect of the €2,500,000,000 Euro Medium Term Note Programme of Rentokil Initial plc.

The Supplementary Prospectus should be read and construed in conjunction with the Base Prospectus dated 5 April 2012.

The Supplementary Prospectus approved today and the Base Prospectus effective from 5 April 2012, have been submitted to the National Storage Mechanism and are available for inspection by searching for documents relating to Rentokil Initial plc at:

www.hemscott.com/nsm.do

To view the Supplementary Prospectus, please paste the following URL in to the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/3548M_-2012-9-14.pdf

Β 

For further information, please contact Stuart Ingall-Tombs, Group Financial Controller & Treasurer at Rentokil Initial plc, 2 City Place, Beehive Ring Road, Gatwick Airport, West Sussex, RH6 0HA. Telephone +44 (0)1293 858000.

Β 

Β 

Β 

Β 

Β 

Β 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries. You must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Notes issued under the Base Prospectus will not be registered under the United States Securities Act of 1933, as amended or any relevant securities laws of any state of the United States and are subject to U.S. tax law requirements. Subject to certain exceptions, Notes issued under the Prospectus may not be offered, sold or delivered in the United States or to or for the account or benefit of U.S. persons.

Your right to access this service is conditional upon complying with the above requirement.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
PDIQZLFFLKFFBBE
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.